The UK National Institute of Clinical Excellence (NICE) have amended their prostate cancer guidelines and now recommend that the national standard for risk stratification for prostate cancer be based on the Cambridge Prognostic Groups (CPG) which was developed in the University of Cambridge Department of Surgery by Professor Vincent J Gnanapragasam and colleagues. The updated […]
Archives for 2021
The BORS meeting will be held online as a virtual conference. The call for abstracts for the Annual Meeting is now open. The deadline for submission is 31st May 2021.
‘The research paves the way for cell therapies to treat liver disease – in other words, growing ‘mini-bile ducts’ in the lab as replacement parts that can be used to restore a patient’s own liver to health – or to repair damaged organ donor livers, so that they can still be used for transplantation.’ University […]
The National Prostate Cancer Audit (NPCA) has published a short report on the use of the Cambridge-developed Cambridge Prognostic Groups for non-metastatic prostate cancer and its utility and benefit in better reporting of treatment trends and patterns in the UK. This follows on from a paper jointly published last year. The NPCA will be used […]